Beyond the Mega-Caps: Surviving the Market's Uncategorized FringeGlobal Report·19 hours agoLPTH-9.45%UPB+0.16%
Abivax SA Stock 12‑Month Price Target Raised to $162.06, Implies 24% UpsideTradingView·Jul 24 at 08:20 AMABVX-4.34%
Sofinnova Crossover I cuts Abivax voting rights stake below 5% to 4.92%PUBT·Jul 24 at 04:12 AMABVX-4.34%
Abivax names new global heads of marketing, sales and market access in commercial leadership shake-upPUBT·Jul 23 at 03:13 PMABVX-4.34%
10 Health Care Stocks With Whale Alerts In Today’s Sessionbenzinga_article·Jul 21 at 12:35 PMABVX-4.34%MRK-1.11%
Abivax reports 87,177,069 issued shares, 89,524,616 voting rights as of July 6, 2026PUBT·Jul 17 at 11:00 AMABVX-4.34%
Valerio Therapeutics enters exclusive R&D collaboration with Abivax, secures up to €2.4 million upfrontPUBT·Jul 16 at 01:11 AMABVX-4.34%
